A research letter highlighted coverage in The New York Times of a small study on oral minoxidil and this story’s connection with an immediate increase in the drug’s prescription rates.
Issuing drug safety communications when people are not paying as much attention has potentially life-threatening consequences, researchers have found. Is the FDA paying attention?
(NEW YORK) — Tuesday, May 24 marked yet another tragic day in America, after a gunman opened fire at an elementary school in rural Texas, leaving 19 children and two teachers dead, and dozens of family members and friends in mourning. As the nation reels […]